Literature DB >> 30277301

When does curatively treated colorectal cancer recur? An Australian perspective.

Mifanwy M Reece1, Pierre H Chapuis1,2, Anil Keshava1,2, Peter Stewart1, Michael Suen1, Matthew J F X Rickard1,2.   

Abstract

BACKGROUND: While most colorectal cancer (CRC) recurrences reportedly occur within 3 years following curative treatment, many studies are limited by short-term follow-up. This study examines the time to recurrence of CRC in a large Australian cohort with a long follow-up period and assesses whether time to recurrence has changed over time.
METHODS: A comprehensive prospective database of patients undergoing resection for CRC is maintained at Concord Hospital, Sydney. Demographic and time to recurrence data were extracted for patients who developed a recurrence following potentially curative resection for colon cancer from 1995 to 2010 and rectal cancer from 1971 to 2010. Non-deceased patients had a minimum of 5 years follow-up.
RESULTS: Between 1995 and 2010, 2575 patients with CRC underwent surgery. After exclusions, 386 had recurrence following potentially curative resection, ranging from 1 to 172.5 months (median 20.3) after treatment. Within 1 year, 27.5% recurred, 57.5% by 2 years, 74.6% by 3 years, 85.5% by 4 years and 89.6% by 5 years. There was no difference in time to recurrence between colon and rectal cancers (P = 0.674). Among patients having a potentially curative resection for rectal cancer between 1971 and 2010, 386 recurred. There was no difference in time to recurrence by decade (P = 0.863).
CONCLUSION: The majority of recurrences occurred within 3 years of curative treatment. Had surveillance been limited to 5 years, detection of more than 10% of recurrences would have been delayed. Time to recurrence for rectal cancer has not changed in over 40 years, despite treatment advances.
© 2018 Royal Australasian College of Surgeons.

Entities:  

Keywords:  colorectal cancer; recurrence; surveillance

Mesh:

Year:  2018        PMID: 30277301     DOI: 10.1111/ans.14870

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  2 in total

1.  The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.

Authors:  Jorja Braden; Prunella Blinman; Ashanya Malalasekera; Kim Kerin-Ayres; Jarrah Spencer; Natalie Southi; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2022-01-18       Impact factor: 4.442

2.  Results of systematic second-look surgery plus hipec in perforated or pt4 colon cancer. Case series.

Authors:  Ángel Serrano Del Moral; Estíbalitz Pérez Viejo; Israel Manzanedo Romero; Fernando Pereira Pérez
Journal:  Ann Med Surg (Lond)       Date:  2021-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.